TP53 and hepatocellular carcinoma: Wang et al. constructed a multifactor model by combining urinary mRASSF1A, mGSTP1, and TP53 249T and serum AFP that could distinguish HCC from hepatitis or cirrhosis with 87% sensitivity and 90% specificity, outperforming AFP alone.